Gene: UBE2B
Official Full Name: ubiquitin conjugating enzyme E2 Bprovided by HGNC
Gene Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is required for post-replicative DNA damage repair. Its protein sequence is 100% identical to the mouse, rat, and rabbit homologs, which indicates that this enzyme is highly conserved in eukaryotic evolution. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34882 | UBE2B Knockout cell line (HeLa) | Human | UBE2B | 1:3~1:6 | Negative | Online Inquiry |
KO34883 | UBE2B Knockout cell line (HCT 116) | Human | UBE2B | 1:2~1:4 | Negative | Online Inquiry |
KO34884 | UBE2B Knockout cell line (HEK293) | Human | UBE2B | 1:3~1:6 | Negative | Online Inquiry |
KO34885 | UBE2B Knockout cell line (A549) | Human | UBE2B | 1:3~1:4 | Negative | Online Inquiry |
UBE2B Gene Knockout Cell Lines are engineered cellular models that specifically lack the ubiquitin-conjugating enzyme E2 B (UBE2B), a pivotal component in the ubiquitin-proteasome system. This system is crucial for regulating protein degradation, cellular signaling, and maintaining protein homeostasis. By utilizing CRISPR/Cas9 gene editing technology, our UBE2B Gene Knockout Cell Lines provide a powerful tool to study intracellular processes influenced by ubiquitination, particularly in the context of various diseases such as cancer, neurodegeneration, and immune disorders.
The primary function of UBE2B involves the transfer of ubiquitin to target proteins, marking them for degradation or modification. By knocking out the UBE2B gene, researchers can elucidate the downstream effects of impaired ubiquitination, enabling them to understand the molecular mechanisms underlying cellular dysfunction. In research settings, these cell lines can be utilized to screen for drug responses, identify potential therapeutic targets, and investigate the roles of UBE2B-related pathways in disease progression.
One of the significant advantages of using our UBE2B Gene Knockout Cell Lines is their specificity and consistency, ensuring that experiments yield reliable, reproducible results. Unlike transient knockdown approaches, these stable knockout lines provide a long-term solution for extensive studies, minimizing variability associated with transient transfection techniques. Additionally, our cell lines are ready to use, saving valuable time in laboratory preparations.
For researchers and clinicians dedicated to advancing our understanding of ubiquitin-mediated processes, these knockout lines offer an invaluable resource. They are particularly beneficial in exploring UBE2B's role in therapeutic resistance and tumor biology.
At our company, we specialize in providing high-quality biological products tailored to the evolving needs of researchers. Our expertise in cellular models, paired with rigorous quality assurance, ensures that our UBE2B Gene Knockout Cell Lines are not only reliable but also equipped to enhance the scientific community's efforts in molecular and translational research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.